Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers.
Zhu Y, Banerjee A, Xie P, Ivanov AA, Uddin A, Jiao Q, Chi JJ, Zeng L, Lee JY, Xue Y, Lu X, Cristofanilli M, Gradishar WJ, Henry CJ, Gillespie TW, Bhave MA, Kalinsky K, Fu H, Bahar I, Zhang B, Wan Y.
Zhu Y, et al. Among authors: bahar i.
J Clin Invest. 2024 Mar 26;134(10):e176390. doi: 10.1172/JCI176390.
J Clin Invest. 2024.
PMID: 38530357
Free PMC article.